12-ID-192: A Phase 1 Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD103-HgR

Grants and Contracts Details

StatusFinished
Effective start/end date4/4/123/31/18

Funding

  • PaxVax Incorporated: $506,578.00